A centennial history of research on asthma pathogenesis

American Journal of Respiratory Cell and Molecular Biology

Volumn 32, Issue 6, 2005, Pages 483-489

  Walter, Michael J ^a   Holtzman, Michael J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALLERGY; ASTHMA; BRONCHOSPASM; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MEDICAL RESEARCH; NERVOUS SYSTEM; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; TH2 CELL; VIRUS INFECTION;

ALLERGY AND IMMUNOLOGY; ANIMALS; ASTHMA; HISTORY, 17TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MOLECULAR BIOLOGY;

EID: 20044363637     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.F300     Document Type: Review

References (86)

1. Veith I. The yellow emperor's classic of internal medicine. Cambridge, England: Cambridge University Press; 1966.
2. Saavedra-Delgado AM, Cohen SG, Huang-Ti, the Yellow Emperor and the Nei Ching: antiquity's earliest reference to asthma. Allergy Proc 1991;12:197-198.
3. Sakula A. A history of asthma. The FitzPatrick lecture 1987. J R Coll Physicians Lond 1988;22:36-44.
4. Marketos S, Ballas C. Bronchial asthma in medical literature of Greek antiquity. Hist Sci Med 1982;17:35-39.
5. Keeney EL. The history of asthma from Hippocrates to Meltzer. J Allergy Clin Immunol 1964;35:215-226.
6. Brodie MD, Dixon TG. The pathology of asthma. Transactions of the Pathological Soc of London 1903;liv:17.
7. Boushey HA, Holtzman MJ, Sheller JR, Nadel JA. Bronchial hyperreactivity. Am Rev Respir Dis 1980;121:389-413.
8. Solway J, Fredberg JJ. Perhaps airway smooth muscle dysfunction contributes to asthmatic bronchial hyperresponsiveness after all. Am J Respir Cell Mol Biol 1997;17:144-146.
9. Holtzman MJ, Kim EY, Morton JD. Genetic and genomic approaches to complex lung diseases using mouse models. In: Peltz G, editor. Computational genetics and genomics: tools for understanding disease. Totowa, NJ: Humana Press Inc.; 2005. pp. 99-141.
10. Bleecker ER. Similarities and differences in asthma and COPD. The Dutch hypothesis. Chest 2004;126:935-955. (discussion 159S-161S).
11. Postma DS, Boezen HM. Rationale for the Dutch hypothesis: allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD. Chest 2004;126:96S-104S. (discussion 159S-161S).
12. Stephens NL, Li W, Jiang H, Unruh H, Ma X. The biophysics of asthmatic airway smooth muscle. Respir Physiol Neurobiol 2003;137:125-140.
13. Roth M, Johnson PR, Borger P, Bihl MP, Rudiger JJ, King GG, Ge Q, Hostettler K, Burgess JK, Black JL, et al. Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N Engl J Med 2004;351:560-574.
14. Reed CE. The pathogenesis of asthma. Med Clin North Am 1974;58:55-63.
15. Persson CG. On the medical history of xanthines and other remedies for asthma: a tribute to HH Salter. Thorax 1985;40:881-886.
16. Stolkind E. The history of bronchial asthma and allergy. Proc R Soc Med 1933;26:1120-1126.
17. West S. Diseases of the organs of respiration. Philadelphia: J. B. Lippincott Company: 1902.
18. Powell RD, Hartley PH. On diseases of the lung and pleurae including tuberculosis & mediastinal growths, 5th ed. Philadelphia: P. Blakiston's Son & Co.; 1911. pp. 215-236.
19. Simonsson BG, Jacobs FM, Nadel JA. Role of autonomic nervous system and the cough reflex in the increased responsiveness of airways in patients with obstructive airway disease. J Clin Invest 1967;46:1812-1818.
20. Szentivanyi A. The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 1968;42:203-232.
21. Maggi CA, Giachetti A, Dey RD, Said SI. Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins. Physiol Rev 1995;75:277-322.
22. McDonald DM, Bowden JJ, Baluk P, Bunnett NW. Neurogenic inflammation: a model for studying efferent actions of sensory nerves. Adv Exp Med Biol 1996;410:453-462.
23. Casale TB, Baraniuk JN. Functional activity of lower airway nerves. In: Busse WW, Holgate ST, editors. Asthma and rhinitis. Cambridge, MA: Blackwell Science; 2000. pp. 866-890.
24. Jartti T. Asthma, asthma medication and autonomic nervous system dysfunction. Clin Physiol 2001;21:260-269.
25. Cooke RA, Vander Veer A. Human sensitization. J Immunol 1916;1:201-305.
26. Wolff-Eisneer A. Das Heufieber: sein Wesen und seine Behandlung. Munchen: Lehmano; 1906.
27. Emanuel MB. Histamine and the antiallergic antihistamines: a history of their discoveries. Clin Exp Allergy 1999;29:1-11. (discussion 12).
28. Magendie F. Lectures on blood. Philadelphia: Harrington, Barrington, and Haswell; 1839.
29. Portier P. De l'action anaphylactique de certains venins. C R Seances Soc Biol Fil 1902;54:170-172.
30. Meltzer SJ. Bronchial asthma as a phenomena of anaphylaxis. JAMA 1910;12:1021-1024.
31. Auer J, Lewis PA. The physiology of the immediate reaction of anaphylaxis in the guinea-pig. J Exp Med 1910;12:151.
32. Huber HL, Koessler KK. The pathology of bronchial asthma. Arch Intern Med 1922;30:689-760.
33. Cecil RL. A text-book of medicine. Philadelphia: W. B. Saunders Company; 1928. pp. 481-489.
34. Walker IC. A clinical study of 400 patients with bronchial asthma. Boston Med Surg J 1918;clxxix:288-300.
35. Norris GW, Landis HR. Bronchial asthma: diseases of the chest and the principles of physical diagnosis. Philadelphia: W. B. Saunders Company; 1918. pp. 270-276.
36. Rackemann FM. A clinical classification of asthma based upon a review of six hundred and forty-eight cases. Am J Med Sci 1921;clxii:802-811.
37. Prausnitz D, Kustner H. Studien uber die Uberempfindlichkeit. Zentralblatt fur Bakteriologie 1921;86:160-175.
38. Ishizaka K, Ishizaka T, Hornbrook MM. Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. J Immunol 1966;97:840-853.
39. Dale HH. Some chemical factors in the control of circulation. Lecture 3. Lancet 1929;i:1285-1290.
40. Katz G, Cohen S. Experimental evidence for histamine release in allergy. JAMA 1941;117:1782-1783.
41. Weiss S, Robb GP, Blumgart HL. The velocity of blood flow in health and disease as measured by the effect of histamine on the minute vessels. Am Heart J 1929;4:664.
42. Holtzman MJ. Epithelial cell regulation of arachidonic acid oxygenation. In: Farmer SG, Hay DWP, editors. The airway epithelium: physiology, pathophysiology, and pharmacology, lung biology in health and disease. New York: Marcel Dekker; 1991. pp. 65-115.
43. Lewis RA, Austen KF, Drazen JM, Clark DA, Marfat A, Corey EJ. Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources. Proc Natl Acad Sci USA 1980;77:3710-3714.
44. Murphy RC, Hammarstrom S, Samuelsson B. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 1979;76:4275-4279.
45. Busse W, Lemanske RF. Asthma. N Engl J Med 2001;344:350-362.
46. 4 by tracheal pithelial cells from dogs. Biochem Biophys Res Commun 1983;114:1071-1076.
47. Djukanovic R, Roche WR, Wilson JW, Beasley CR, Twentyman OP, Howarth RH, Holgate ST. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-457.
48. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-1745.
49. Vignola AM, Chanez P, Campbell AM, Souques F, Lebel B, Enander I, Bousquet J. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 1998;157:403-409.
50. De Monchy JG, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, De Vries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985;131:373-376.
51. Metzger WJ, Zavala D, Richerson HB, Moseley P, Iwamota P, Monick M, Sjoerdsma K, Hunninghake GW. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am Rev Respir Dis 1987;135:433-440.
52. Laitinen LA, Laitinen A, Heino M, Haahtela T. Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid. Am Rev Respir Dis 1991;143:423-427.
53. Herxheimer H. The late bronchial reaction in induced asthma. Int Arch Allergy Appl Immunol 1952;3:323-328.
54. Booij-Noord H, Orie NG, De Vries K. Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. J Allergy Clin Immunol 1971;48:344-354.
55. Burge PS, Efthimiou J, Turner-Warwick M, Nelmes PT. Double-blind trials of inhaled beclomethasone diproprionate and fluocortin butyl ester in allergen-induced immediate and late asthmatic reactions. Clin Allergy 1982;12:523-531.
56. Dworski R, Fitzgerald GA, Oates JA, Sheller JR. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994;149:953-959.
57. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995;332:868-875.
58. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis 1991;143:1317-1321.
59. Haahtela T, Vidgren M, Nyberg A, Korhonen P, Laurikainen K, Silvasti M. A novel multiple dose powder inhaler: salbutamol powder and aerosol give equal bronchodilatation with equal doses. Ann Allergy 1994;72:178-182.
60. Hart L, Lim S, Adcock I, Barnes PJ, Chung KF. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor-κB in asthma. Am J Respir Crit Care Med 2000;161:224-231.
61. Castro M, Bloch SR, Jenkerson MV, DeMartino S, Hamilos DL, Cochran RB, Zhang XE, Wang H, Bradley JP, Schechtman KB, et al. Asthma exacerbations after glucocorticoid withdrawal reflects T cell recruitment to the airway. Am J Respir Crit Care Med 2004;169:842-849.
62. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-2357.
63. H2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
64. Holtzman MJ. Where are the gaps in asthma research? A counter-perspective. J Allergy Clin Immunol 2003;111:244-247.
65. Cembrzynska-Nowak M, Szklarz E, Inglot AD, Teodorczyk-Injeyan JA. Elevated release of tumor necrosis factor-α and Interferon-γ by bronchoalveolar leukocytes from patients with bronchial asthma. Am Rev Respir Dis 1993;147:291-295.
66. Krug N, Madden J, Redington AE, Lackie P, Djukanovic R, Schauer U, Holgate ST, Frew AJ, Howarth PH. T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol 1996;14:319-326.
67. Sampath D, Castro M, Look DC, Holzman MJ. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway on asthma. J Clin Invest 1999;103:1353-1361.
68. Ashwell JD, Lu FW, Vacchio MS. Glucocorticoids in T cell development and function*. Annu Rev Immunol 2000;18:309-345.
69. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148.
70. Bryan SA, O'Connor BJ, Matti S, Leckie MJ, Kanabar V, Khan J, Warrington SJ, Renzetti L, Rames A, Bock JA, et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness and the late asthmatic response. Lancet 2000;356:2149-2153.
71. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000;343:338-344.
72. Holtzman MJ, Castro M, Look DC, O'Sullivan M, Walter MJ. Regulation of epithelial-leukocyte interactions and epithelial immune-response genes. In: Busse W, Holgate S, editors. Asthma and Rhinitis. Cambridge, MA: Blackwell Scientific; 2000. pp. 784-800.
73. Holtzman MJ, Morton JD, Shornick LP, Tyner JW, O'Sullivan MP, Antao A, Lo M, Castro M, Walter MJ. Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm. Physiol Rev 2002;82:19-46.
74. Panettieri RA Jr. Airway smooth muscle: immunomodulatory cells? Allergy Asthma Proc 2004;25:381-386.
75. Randolph DA, Carruthers CJ, Szabo SJ, Murphy KM, Chaplin DD. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 1999;162:2375-2383.
76. Hansen G, Berry G, DeKruyff RH, Umetsu DT. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999;103:175-183.
77. Lemanske RF Jr. Viruses and asthma: Inception, exacerbation, and possible prevention. J Pediatr 2003;142:S3-S7. (discussion S7-S8).
78. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-545.
79. Walter MJ, Morton JD, Kajiwara N, Agapov E, Holtzman MJ. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest 2002;110:165-175.
80. Lo MS, Brazas RM, Holtzman MJ. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and type I interferon responsiveness. J Virol 2005; (in press).
81. Sumino KC, Agapov E, Pierce RA, Trulock EP, Pfeifer JD, Ritter JH, Gaudreault-Keener M, Storch GA, Holtzman MJ. Detection of severe human metapneumovirus infection by real-time PCR and distinct histopathology. J Infect Dis (In press)
82. Weiss ST, Raby BA. Asthma genetics 2003. Hum Mol Genet 2004;13: R83-R89.
83. Cookson W, Moffatt M. Making sense of asthma genes. N Engl J Med 2004;351:1794-1796.
84. Kere J, Laitinen T. Positionally cloned susceptibility genes in allergy and asthma. Curr Opin Immunol 2004;16:689-694.
85. Grayson MH, Holtzman MJ. Asthma. In: Dale DC, editor. ACPMedicine. New York: WebMD Publishing; 2005.
86. Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, Deykin A, Fagan JK, Fahy JV, Fish J, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004;364:1505-1512.